Works matching DE "TRANSLATIONAL Research in Oncology (Company)"

FDA Approves TCH Combination for HER2 -Positive Early Breast Cancer.

Published in:

Oncology (08909091), 2008, v. 22, n. 7, p. 762

Publication type:

Article